Information card for entry 7053004

Structure parameters

• Common name: [(2,2'bipyridine)di(flumequinato-κ^2^O,O)zinc(II)] dihydrate
• Chemical name: [(2,2'bipyridine)di(9-fluoro-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylato-κ^2^O,O)zinc(II)] dihydrate
• Formula: C38 H34 F2 N4 O8 Zn
• Calculated formula: C38 H34 F2 N4 O8 Zn
• Title of publication: Zinc(II) complexes with the quinolone antibacterial drug flumequine: structure, DNA- and albumin-binding
• Authors of publication: Tarushi, Alketa; Kljun, Jakob; Turel, Iztok; Pantazaki, Anastasia A.; Psomas, George; Kessissoglou, Dimitris P.
• Journal of publication: New Journal of Chemistry
• Year of publication: 2013
• Journal volume: 37
• Journal issue: 2
• Pages of publication: 342
• a: 9.1543 ± 0.0003 Å
• b: 9.4031 ± 0.0003 Å
• c: 20.9383 ± 0.0007 Å
• α: 77.882 ± 0.002°
• β: 79.291 ± 0.002°
• γ: 83.454 ± 0.002°
• Cell volume: 1726.21 ± 0.1 ų
• Cell temperature: 150 ± 2 K
• Ambient diffraction temperature: 150 ± 2 K
• Number of distinct elements: 6
• Space group number: 2
• Hermann-Mauguin space group symbol: P -1
• Hall space group symbol: -P 1
• Residual factor for all reflections: 0.1
• Residual factor for significantly intense reflections: 0.0526
• Weighted residual factors for significantly intense reflections: 0.091
• Weighted residual factors for all reflections included in the refinement: 0.1063
• Goodness-of-fit parameter for all reflections included in the refinement: 1.028
• Diffraction radiation wavelength: 0.71073 Å
• Diffraction radiation type: MoKα
• Has coordinates: Yes
• Has disorder: Yes
• Has Fobs: No